Water
- Manufacturer
- Apotheca Company
- Effective date
- 2011-01-25
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:03
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Betula pendula, cortex 4X, Lappa major 4X, Plantago major 4X, Taraxacum officinale 4X.
OTC - PURPOSE SECTION
USES: For fast temporary relief of water retention. Results are usually felt within hours or days, and increase with longer use.
WARNINGS SECTION
WARNINGS: Stop use and ask a doctor if symptoms continue or get worse, or if new symptoms occur.
If pregnant or nursing ask a doctor before use.
Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: Adults and children 12 or over take 2 capsules every 4-8 hours as needed. Once desired results are obtained try 1-2 capsules twice daily for maintenance. May be used indefinitely if desired, or as needed for seasonal or temporary conditions.
INACTIVE INGREDIENT SECTION
OTHER INGREDIENTS: Birch leaf. Burdock root, Dandelion root, Buchu leaf, Couch grass rhizome, Juniper berry, Microcrystalline cellulose, cellulose capsule.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN.
INDICATIONS & USAGE SECTION
USES: For fast temporary relief of water retention. Results are usually felt within hours or days, and increase with longer use.
OTC - QUESTIONS SECTION
Manufactured for:
RidgeCrest Herbals, Inc.
3683 West 2270 South, Suite A
Salt Lake City, UT 84120-2306
1-800-242-4649
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Water X
NOW IN VEGETARIAN CAPS
HOMEOPATHIC DIURETIC
WITH HERBAL SUPPORT
60 CAPSULES
RidgeCrest Herbals
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57520-0595-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5cdd-f424-e053-dadaa90a57ce | Water X |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57520-0595-1 | Water X | 30 g in 1 BOTTLE | CAPSULE | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57520-0595 | WATER (BETULA PENDULA, CORTEX, LAPPA MAJOR, PLANTAGO MAJOR, TARAXACUM OFFICINALE,) CAPSULE [APOTHECA COMPANY] | 1 | Legacy NDC, 1 package rows | 20110126_9e9018e1-f874-49f4-8824-5e0f8360e8b0.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARCTIUM LAPPA ROOT | ACTIVE INGREDIENT | 597E9BI3Z3 | 1 | |
| BETULA PENDULA BARK | ACTIVE INGREDIENT | 40S83Y133C | 1 | |
| PLANTAGO MAJOR | ACTIVE INGREDIENT | W2469WNO6U | 1 | |
| TARAXACUM OFFICINALE | ACTIVE INGREDIENT | 39981FM375 | 1 | |
| ARCTIUM LAPPA ROOT | ACTIVE MOIETY | 597E9BI3Z3 | 1 | |
| BETULA PENDULA BARK | ACTIVE MOIETY | 40S83Y133C | 1 | |
| PLANTAGO MAJOR | ACTIVE MOIETY | W2469WNO6U | 1 | |
| TARAXACUM OFFICINALE | ACTIVE MOIETY | 39981FM375 | 1 | |
| AGATHOSMA BETULINA LEAF | INACTIVE INGREDIENT | 369DDH39Z0 | 1 | |
| ARCTIUM LAPPA ROOT | INACTIVE INGREDIENT | 597E9BI3Z3 | 1 | |
| BETULA PUBESCENS LEAF | INACTIVE INGREDIENT | 84SOH0O3OO | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| ELYMUS REPENS ROOT | INACTIVE INGREDIENT | 3IXW0F6P8W | 1 | |
| JUNIPERUS COMMUNIS FRUIT | INACTIVE INGREDIENT | O84B5194RL | 1 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | 1 | |
| TARAXACUM OFFICINALE ROOT | INACTIVE INGREDIENT | 9DE5YCO0RU | 1 |
Products#
Every source-derived product name is available through these pages.
- Water X
- Betula pendula, cortex, Lappa major, Plantago major, Taraxacum officinale,
- BETULA PENDULA BARK
- ARCTIUM LAPPA ROOT
- PLANTAGO MAJOR
- TARAXACUM OFFICINALE
- CELLULOSE, MICROCRYSTALLINE
- BETULA PUBESCENS LEAF
- TARAXACUM OFFICINALE ROOT
- AGATHOSMA BETULINA LEAF
- ELYMUS REPENS ROOT
- JUNIPERUS COMMUNIS FRUIT
- POWDERED CELLULOSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57520-0595 | 57520-0595-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | CAPSULE / ORAL | 2430 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | PASTE, DENTIFRICE / DENTAL | NA | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, CHEWABLE / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | LIQUID / ORAL | NA | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | POWDER, FOR SUSPENSION / ORAL | 1600 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, FILM COATED / ORAL | 392 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DISC / TOPICAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / SUBLINGUAL | 43.2 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, EXTENDED RELEASE / ORAL | 156 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DROPS / ORAL | NA | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | DISC / EXTRACORPOREAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / BUCCAL | 4.5 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, COATED / ORAL | 40.2 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, DELAYED RELEASE / ORAL | 16 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | SUSPENSION / ORAL | 1600 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE / ORAL | 29520 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / SUBLINGUAL | 4.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION / ORAL | 1600 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d3471a2c-00f3-40a1-9109-d01c83d1ab6b | 9e9018e1-f874-49f4-8824-5e0f8360e8b0 | 2011-01-25 | Warnings | d3471a2c-00f3-40a1-9109-d01c83d1ab6b 9e9018e1-f874-49f4-8824-5e0f8360e8b0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
